• LAST PRICE
    42.5150
  • TODAY'S CHANGE (%)
    Trending Up1.4650 (3.5688%)
  • Bid / Lots
    42.4100/ 1
  • Ask / Lots
    42.8900/ 2
  • Open / Previous Close
    41.6400 / 41.0500
  • Day Range
    Low 41.2550
    High 43.3850
  • 52 Week Range
    Low 26.7000
    High 82.0000
  • Volume
    14,296
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 41.05
TimeVolumeSMLR
09:39 ET69941.69
09:42 ET15041.255
09:46 ET22541.6
09:48 ET20042.06
09:53 ET30042.0301
09:57 ET50042.0276
10:02 ET10042.02
10:04 ET10042.01
10:06 ET173742.59
10:08 ET151543.385
10:09 ET71542.57
10:27 ET60042.6999
10:29 ET10042.5
10:38 ET10042.65
10:44 ET30042.7
11:09 ET15542.5
11:18 ET10042.525
11:20 ET10042.615
11:27 ET61042.85
12:01 ET10043.13
12:08 ET10042.99
12:30 ET20042.515
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSMLR
Semler Scientific Inc
280.8M
26.9x
---
United StatesLUNG
Pulmonx Corp
352.4M
-6.1x
---
United StatesAATP
Agape ATP Corp
302.6M
-292.3x
---
United StatesTELA
TELA Bio Inc
219.9M
-4.0x
---
United StatesCVRX
CVRx Inc
343.1M
-9.2x
---
United StatesINFU
InfuSystem Holdings Inc
219.0M
870.9x
---
As of 2023-02-02

Company Information

Semler Scientific, Inc. provides technology solutions to healthcare providers. The Company develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. It also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The Company's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.

Contact Information

Headquarters
2340-2348 Walsh Avenue, Suite 2344SANTA CLARA, CA, United States 95051
Phone
408-627-4557
Fax
302-636-5454

Executives

Chief Executive Officer, Director
Douglas Murphy-Chutorian
Principal Financial Officer, Senior Vice President - Finance and Accounting
Andrew Weinstein
Vice President - Finance
Daniel Conger
Independent Director
Arthur Leibowitz
Independent Director
Daniel Messina

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$280.8M
Revenue (TTM)
$54.4M
Shares Outstanding
6.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.70
EPS
$1.58
Book Value
$6.74
P/E Ratio
26.9x
Price/Sales (TTM)
5.2
Price/Cash Flow (TTM)
21.2x
Operating Margin
28.10%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.